Citi Upgrades Larimar Therapeutics (LRMR) to Buy, 'Current Valuation Shifts Risk/Reward Favorably'
Tweet Send to a Friend
(Updated - November 16, 2023 4:32 PM EST)
Citi analyst Samantha Semenkow upgraded Larimar Therapeutics (NASDAQ: LRMR) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Samantha Semenkow upgraded Larimar Therapeutics (NASDAQ: LRMR) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
